Leo Brokerage’s AbbVie ABBV Stock Holding History

Leo Brokerage’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.54M	Buy	18,818 +2,046	+12%	+$300K	0.29%	54
2023 Q1	$2.67M	Buy	+16,772	New	+$2.56M	0.4%	46
2022 Q2	$1.5M	Sell	9,779 -1,176	-11%	-$180K	0.4%	49
2022 Q1	$1.78M	Buy	+10,955	New	+$1.59M	0.28%	60
2021 Q3	$995K	Buy	9,220 +1,208	+15%	+$138K	0.18%	61
2021 Q2	$902K	Hold	8,012	–	–	0.18%	71
2021 Q1	$867K	Sell	8,012 -204	-2%	-$21.8K	0.25%	64
2020 Q4	$880K	Buy	8,216 +3,791	+86%	+$364K	0.28%	59
2020 Q3	$434K	Buy	+4,425	New	+$417K	0.18%	72

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Leo Brokerage's ABBV Position: Q2 2023 in Review

Leo Brokerage increased its AbbVie (ABBV) stake by 12% in Q2 2023, buying an estimated $300K and bringing the position to 18,818 shares worth $2.54M. The position accounts for 0.29% of the portfolio, ranked #54.

Leo Brokerage first reported a position in ABBV in Q3 2020 and has held it in 9 quarters since. The position peaked at $2.67M in Q1 2023. 3,079 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Leo Brokerage held 18,818 shares of AbbVie worth $2.54M as of Q2 2023.
Leo Brokerage bought 2,046 AbbVie shares in Q2 2023, an estimated $300K.
AbbVie made up 0.29% of Leo Brokerage's portfolio in Q2 2023, its #54 holding.
Leo Brokerage first reported a position in AbbVie in Q3 2020 and has held it in 9 quarters since.
Leo Brokerage's AbbVie position peaked at $2.67M in Q1 2023.
3,079 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.